• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Depression in Parkinson disease: a disabling but neglected factor.

作者信息

Cantello R, Riccio A, Scarzella L, Leotta D, Bergamasco B

出版信息

Ital J Neurol Sci. 1984 Dec;5(4):417-22. doi: 10.1007/BF02042626.

DOI:10.1007/BF02042626
PMID:6530364
Abstract

20 depressed and 20 non depressed patients with Parkinson disease were rated for disability on the Northwestern University Disability Scale and for severity of the "typical" motor symptoms on the Columbia University Rating Scale and were assessed for mental deterioration. The severity of the "typical" symptoms was practically equivalent in the two groups but the depressed patients not only presented mild mental deterioration but were significantly more disabled (less independent) than the patients without depression. A significant correlation was found between severity of depression and degree of disability but not between severity of depression and severity of "typical" motor symptoms. Depression was diagnosed much later than the "typical" symptoms. Only 25% of the depressed parkinsonians had received tricyclic antidepressants, about 20% had been treated with dopamine-antagonist psychotropic drugs and some 50% had received no treatment at all against depression. Timely diagnosis and appropriate treatment of depression in parkinsonian patients limits the effects of a major disabling factor.

摘要

相似文献

1
Depression in Parkinson disease: a disabling but neglected factor.
Ital J Neurol Sci. 1984 Dec;5(4):417-22. doi: 10.1007/BF02042626.
2
The longitudinal impact of depression on disability in Parkinson disease.抑郁症对帕金森病残疾的纵向影响。
Int J Geriatr Psychiatry. 2016 May;31(5):458-65. doi: 10.1002/gps.4350. Epub 2015 Aug 18.
3
Effect of reboxetine on depression in Parkinson's disease patients.瑞波西汀对帕金森病患者抑郁的影响。
J Clin Psychiatry. 2002 Apr;63(4):300-4. doi: 10.4088/jcp.v63n0405.
4
Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety.抑郁评定量表在伴或不伴共病焦虑的帕金森病患者中的应用。
J Parkinsons Dis. 2013;3(4):603-8. doi: 10.3233/JPD-130264.
5
Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.基于非运动症状的初发帕金森病临床表型
Arch Gerontol Geriatr. 2015 Nov-Dec;61(3):517-22. doi: 10.1016/j.archger.2015.07.001. Epub 2015 Jul 6.
6
Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease.三环类抗抑郁药可延缓早期帕金森病患者对多巴胺能治疗的需求。
Mov Disord. 2012 Jun;27(7):880-7. doi: 10.1002/mds.24978. Epub 2012 May 3.
7
Depressive symptoms in Parkinson's disease.帕金森病中的抑郁症状。
Compr Psychiatry. 2012 Aug;53(6):727-31. doi: 10.1016/j.comppsych.2011.11.002. Epub 2011 Dec 30.
8
Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?帕金森病中的抑郁性疾病——是否预示着更晚期、更广泛的神经退行性变过程?
Acta Neurol Scand. 2008 May;117(5):295-304. doi: 10.1111/j.1600-0404.2007.00986.x. Epub 2008 Feb 13.
9
[Parkinson disease and depression: a research carried out with the neurology service at S. Joao Hospital].[帕金森病与抑郁症:在圣若昂医院神经科开展的一项研究]
Acta Med Port. 1990 Mar-Apr;3(2):95-100.
10
Parkinson's disease and anxiety: comorbidity with depression.帕金森病与焦虑症:与抑郁症的共病情况。
Biol Psychiatry. 1993 Oct 1;34(7):465-70. doi: 10.1016/0006-3223(93)90237-8.

引用本文的文献

1
Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study.帕金森病中与“剂量末期恶化”相关的情绪变化:一项对照研究。
J Neurol Neurosurg Psychiatry. 1986 Oct;49(10):1182-90. doi: 10.1136/jnnp.49.10.1182.
2
Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse.帕金森病中的重度抑郁症以及对静脉注射哌醋甲酯的情绪反应:“享乐性”多巴胺突触的可能作用
J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):724-31. doi: 10.1136/jnnp.52.6.724.

本文引用的文献

1
A rating scale for depression.一种抑郁症评定量表。
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
2
IMIPRAMINE IN TREATMENT OF PARKINSONISM: A DOUBLE-BLIND PLACEBO STUDY.丙咪嗪治疗帕金森病:一项双盲安慰剂研究。
Br Med J. 1965 Jul 3;2(5452):33-4. doi: 10.1136/bmj.2.5452.33.
3
A method for evaluating disability in patients with Parkinson's disease.一种评估帕金森病患者残疾程度的方法。
J Nerv Ment Dis. 1961 Aug;133:143-7. doi: 10.1097/00005053-196108000-00010.
4
An inventory for measuring depression.一份用于测量抑郁的量表。
Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004.
5
Depression, intellectual impairment, and Parkinson disease.抑郁症、智力障碍与帕金森病。
Neurology. 1981 Jun;31(6):645-50. doi: 10.1212/wnl.31.6.645.
6
Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA.帕金森病的抗抑郁治疗。去甲替林对接受左旋多巴治疗的帕金森病患者疗效的对照试验。
Acta Neurol Scand. 1980 Oct;62(4):210-9. doi: 10.1111/j.1600-0404.1980.tb03028.x.
7
Evaluating the evaluations: or how to weigh the scales of parkinsonian disability.评估各项评估:或如何权衡帕金森病残疾程度的衡量标准。
Neurology. 1983 Aug;33(8):1098-9. doi: 10.1212/wnl.33.8.1098.
8
Treatment of parkinsonism with levodopa.左旋多巴治疗帕金森症。
Arch Neurol. 1969 Oct;21(4):343-54. doi: 10.1001/archneur.1969.00480160015001.
9
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.老年受试者痴呆症的定量测量与大脑灰质老年变化之间的关联。
Br J Psychiatry. 1968 Jul;114(512):797-811. doi: 10.1192/bjp.114.512.797.
10
The Beck depression inventory with medical inpatients.
Acta Psychiatr Scand. 1967;43(3):255-66. doi: 10.1111/j.1600-0447.1967.tb05762.x.